321 related articles for article (PubMed ID: 16935388)
1. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury.
Velayudham A; Hritz I; Dolganiuc A; Mandrekar P; Kurt-Jones E; Szabo G
J Hepatol; 2006 Dec; 45(6):813-24. PubMed ID: 16935388
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
3. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
4. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation.
Johnson AC; Heinzel FP; Diaconu E; Sun Y; Hise AG; Golenbock D; Lass JH; Pearlman E
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):589-95. PubMed ID: 15671286
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
7. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
[TBL] [Abstract][Full Text] [Related]
8. Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice.
Imamura M; Tsutsui H; Yasuda K; Uchiyama R; Yumikura-Futatsugi S; Mitani K; Hayashi S; Akira S; Taniguchi S; Van Rooijen N; Tschopp J; Yamamoto T; Fujimoto J; Nakanishi K
J Hepatol; 2009 Aug; 51(2):333-41. PubMed ID: 19501931
[TBL] [Abstract][Full Text] [Related]
9. Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a MyD88-dependent pathway, without the requirement of TLR2, TLR4, TLR5 and TLR9.
Lapaque N; Muller A; Alexopoulou L; Howard JC; Gorvel JP
Microb Pathog; 2009 Dec; 47(6):299-304. PubMed ID: 19747534
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock.
Prince JM; Levy RM; Yang R; Mollen KP; Fink MP; Vodovotz Y; Billiar TR
J Am Coll Surg; 2006 Mar; 202(3):407-17. PubMed ID: 16500244
[TBL] [Abstract][Full Text] [Related]
13. Pathological role of Toll-like receptor signaling in cerebral malaria.
Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S
Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446
[TBL] [Abstract][Full Text] [Related]
14. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages.
Franchini M; Schweizer M; Mätzener P; Magkouras I; Sauter KS; Mirkovitch J; Peterhans E; Jungi TW
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):37-49. PubMed ID: 16216336
[TBL] [Abstract][Full Text] [Related]
15. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.
Lichtnekert J; Vielhauer V; Zecher D; Kulkarni OP; Clauss S; Segerer S; Hornung V; Mayadas TN; Beutler B; Akira S; Anders HJ
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F867-74. PubMed ID: 19158348
[TBL] [Abstract][Full Text] [Related]
16. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans.
Biondo C; Midiri A; Messina L; Tomasello F; Garufi G; Catania MR; Bombaci M; Beninati C; Teti G; Mancuso G
Eur J Immunol; 2005 Mar; 35(3):870-8. PubMed ID: 15714580
[TBL] [Abstract][Full Text] [Related]
17. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
18. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
Remer KA; Brcic M; Sauter KS; Jungi TW
J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
[TBL] [Abstract][Full Text] [Related]
19. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
